DiaSorin Future Growth
Future criteria checks 2/6
DiaSorin is forecast to grow earnings and revenue by 13.6% and 7.7% per annum respectively. EPS is expected to grow by 12.6% per annum. Return on equity is forecast to be 13.2% in 3 years.
Key information
13.6%
Earnings growth rate
12.6%
EPS growth rate
Medical Equipment earnings growth | 22.5% |
Revenue growth rate | 7.7% |
Future return on equity | 13.2% |
Analyst coverage | Good |
Last updated | 28 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,393 | 252 | 275 | 386 | 11 |
12/31/2025 | 1,284 | 216 | 242 | 344 | 12 |
12/31/2024 | 1,191 | 187 | 210 | 297 | 11 |
9/30/2024 | 1,178 | 189 | 258 | 372 | N/A |
6/30/2024 | 1,161 | 168 | 190 | 321 | N/A |
3/31/2024 | 1,147 | 164 | 232 | 346 | N/A |
12/31/2023 | 1,148 | 160 | 198 | 312 | N/A |
9/30/2023 | 1,195 | 150 | 195 | 308 | N/A |
6/30/2023 | 1,252 | 188 | 250 | 355 | N/A |
3/31/2023 | 1,293 | 200 | 182 | 296 | N/A |
12/31/2022 | 1,361 | 241 | 276 | 389 | N/A |
9/30/2022 | 1,391 | 285 | 289 | 407 | N/A |
6/30/2022 | 1,408 | 302 | 285 | 407 | N/A |
3/31/2022 | 1,329 | 315 | 316 | 433 | N/A |
12/31/2021 | 1,238 | 311 | 283 | 401 | N/A |
9/30/2021 | 1,130 | 315 | 366 | 406 | N/A |
6/30/2021 | 1,014 | 303 | 281 | 373 | N/A |
3/31/2021 | 973 | 288 | 276 | 351 | N/A |
12/31/2020 | 881 | 248 | 230 | 305 | N/A |
9/30/2020 | 791 | 212 | 205 | 261 | N/A |
6/30/2020 | 738 | 186 | 181 | 245 | N/A |
3/31/2020 | 710 | 173 | 185 | 240 | N/A |
12/31/2019 | 706 | 176 | 177 | 233 | N/A |
9/30/2019 | 700 | 168 | 195 | 248 | N/A |
6/30/2019 | 688 | 161 | 159 | 214 | N/A |
3/31/2019 | 675 | 160 | 167 | 220 | N/A |
12/31/2018 | 669 | 158 | 157 | 210 | N/A |
9/30/2018 | 663 | 161 | 132 | 175 | N/A |
6/30/2018 | 649 | 154 | N/A | 179 | N/A |
3/31/2018 | 644 | 145 | N/A | 154 | N/A |
12/31/2017 | 637 | 140 | N/A | 167 | N/A |
9/30/2017 | 625 | 125 | N/A | 174 | N/A |
6/30/2017 | 622 | 125 | N/A | 174 | N/A |
3/31/2017 | 602 | 121 | N/A | 183 | N/A |
12/31/2016 | 569 | 112 | N/A | 166 | N/A |
9/30/2016 | 544 | 111 | N/A | 160 | N/A |
6/30/2016 | 520 | 106 | N/A | 151 | N/A |
3/31/2016 | 506 | 102 | N/A | 138 | N/A |
12/31/2015 | 499 | 100 | N/A | 138 | N/A |
9/30/2015 | 486 | 95 | N/A | 124 | N/A |
6/30/2015 | 472 | 93 | N/A | 123 | N/A |
3/31/2015 | 455 | 87 | N/A | 119 | N/A |
12/31/2014 | 444 | 84 | N/A | 120 | N/A |
9/30/2014 | 437 | 84 | N/A | 114 | N/A |
6/30/2014 | 432 | 82 | N/A | 112 | N/A |
3/31/2014 | 435 | 82 | N/A | 112 | N/A |
12/31/2013 | 435 | 83 | N/A | 108 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DIAM's forecast earnings growth (13.6% per year) is above the savings rate (2.1%).
Earnings vs Market: DIAM's earnings (13.6% per year) are forecast to grow slower than the UK market (14.8% per year).
High Growth Earnings: DIAM's earnings are forecast to grow, but not significantly.
Revenue vs Market: DIAM's revenue (7.7% per year) is forecast to grow faster than the UK market (3.5% per year).
High Growth Revenue: DIAM's revenue (7.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DIAM's Return on Equity is forecast to be low in 3 years time (13.2%).